Exploring the Discovery & Development of an Oral Trispecific Cancer Drug
Time: 11:45 am
day: Day One
Details:
- Developing new understanding of existing targets and their functions
- Acquiring awareness of novel targets and the potential for new inhibitor development
- Combining multiple cancer fighting properties in one drug and advancing clinical biomarker utility in the epigenetic space
Claes Wahlestedt" alt="Claes Wahlestedt" itemprop="image">